Why is it of importance to Government, the National Health Service, and medical device companies to consider new developments in antimicrobial surfaces?
• Conventional approaches are not sufficient to tackle biofilms and surface attached cells. • Developing effective, low-cost strategies to fight HCAI and AMR is a key target for government and health service providers. • Minimising health and safety risks. • Regulatory Changes. Concerns about environmental pollution and toxicity are leading to regulatory changes, limiting the use of previously widely employed solutions • Greener product formulations for biofilm control.
Last edited by Alf; 12/08/246:57 PM.
Darren Magee International Advisor, Consultant & Subject Matter Expert - STEM Ambassador - EBME/MPCE/Decontamination - Medical Device Designer - Environment Solution